Roger S Jackson 2nd
Overview
Explore the profile of Roger S Jackson 2nd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jackson 2nd R, Placzek W, Fernandez A, Ziaee S, Chu C, Wei J, et al.
Neoplasia
. 2012 Aug;
14(7):656-65.
PMID: 22904682
Resistance to available therapeutic agents has been a common problem thwarting progress in treatment of castrate-resistant and metastatic prostate cancer (PCa). Overexpression of the Bcl-2 family members, including Mcl-1, in...
2.
Kiskowski M, Jackson 2nd R, Banerjee J, Li X, Kang M, Iturregui J, et al.
Cancer Res
. 2011 Mar;
71(10):3459-70.
PMID: 21444670
Prostate cancer develops through a stochastic mechanism whereby precancerous lesions on occasion progress to multifocal adenocarcinoma. Analysis of human benign and cancer prostate tissues revealed heterogeneous loss of TGF-β signaling...
3.
Franco O, Jiang M, Strand D, Peacock J, Fernandez S, Jackson 2nd R, et al.
Cancer Res
. 2011 Feb;
71(4):1272-81.
PMID: 21303979
Carcinoma-associated fibroblasts (CAF) play a critical role in malignant progression. Loss of TGF-β receptor II (TGFβR2) in the prostate stroma is correlated with prostatic tumorigenesis. To determine the mechanisms by...
4.
Jackson 2nd R, Franco O, Bhowmick N
Differentiation
. 2008 May;
76(6):606-23.
PMID: 18494814
Stromal-epithelial interactions mediated by paracrine signaling mechanisms dictate prostate development and progression of prostate cancer. The regulatory role of androgens in both the prostate stromal and epithelial compartments set the...
5.
Jackson 2nd R, Cho Y, Stein S, Liang P
Cell Cycle
. 2007 Jan;
6(1):95-103.
PMID: 17245118
A number of target genes for the tumor suppressor, p53, have been identified, however, the mechanisms that contribute to p53-dependent apoptosis remain to be fully elucidated. In a comprehensive screen...
6.
Jackson 2nd R, Cho Y, Liang P
Cell Cycle
. 2006 Dec;
5(24):2889-93.
PMID: 17172869
A number of target genes for the tumor suppressor, p53, have been identified, however, the mechanisms that contribute to p53-dependent apoptosis remain to be fully elucidated. In a comprehensive screen...
7.
Stein S, Thomas E, Herzog B, Westfall M, Rocheleau J, Jackson 2nd R, et al.
J Biol Chem
. 2004 Sep;
279(47):48930-40.
PMID: 15377670
Although a number of target genes for the tumor suppressor p53 have been described, the mechanism of p53-dependent apoptosis is incompletely understood. Thus, it is essential to identify and characterize...
8.
Stein S, Cho Y, Jackson 2nd R, Liang P
Methods Mol Biol
. 2003 Jun;
234:51-63.
PMID: 12824524
Differential display (DD) is a method used worldwide for identifying differentially expressed genes in eukaryotic cells. The mRNA DD technology works by systematic amplification of the 3' terminal regions of...
9.
Ubels J, Aupperlee M, Jackson 2nd R, Van Dyken S, McCartney M
Adv Exp Med Biol
. 2003 Mar;
506(Pt A):317-21.
PMID: 12613927
No abstract available.
10.
Ubels J, Wertz J, Ingersoll K, Jackson 2nd R, Aupperlee M
Exp Eye Res
. 2002 Nov;
75(5):561-71.
PMID: 12457868
Androgens and retinoids are known to be involved in control of lacrimal gland function. Because retinoids generally antagonize androgen function it was the purpose of this study to investigate interactions...